North America Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others). By Country and Growth Forecast, 2024 - 2031

The North America Inhalation Capsules Market would witness market growth of 5.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $332.8 Million by 2031. The Canada market is experiencing a CAGR of 7.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.6% during (2024 - 2031).

Asthma, COPD, and cystic fibrosis are among the respiratory diseases whose prevalence continues to increase due to air pollution, smoking, and an aging population. As per the World Health Organization, chronic obstructive pulmonary disease accounted for 3.23 million fatalities in 2019, placing it as the third leading cause of death. The majority of COPD-related fatalities among individuals aged 70 and below transpire in low and middle-income nations (LMIC). As a result, a growing population requires ongoing management and treatment for respiratory conditions, which drives the demand for inhalation capsules.

Additionally, household air pollution exposure leads to noncommunicable diseases, including stroke, ischemic heart disease, chronic obstructive pulmonary disease (COPD), and lung cancer. Women and children, typically responsible for household chores such as cooking and collecting firewood, bear the greatest health burden from using polluting fuels and technologies in homes. More than 237,000 children under the age of five perished annually due to household air pollution in 2020, according to estimates.

The prevalence of asthma in North America has been on the rise, affecting millions of individuals across the continent. For example, according to the Centers for Disease Control and Prevention (CDC), the percentage of adults aged 18 and older who had asthma was 8.7% in 2022. According to the Department of Health of New York State, in 2021, an estimated 1.4 million adults and over 315,000 children had asthma. Hence, the increasing prevalence of asthma in North America is driving the demand for inhalation therapy, further aiding in the growth of the inhalation capsules market.

Free Valuable Insights: The Inhalation Capsules Market is Predict to reach USD 1.4 Billion by 2031, at a CAGR of 5.9%

Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Cipla Limited
• Novartis AG
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Lonza Group Ltd. (Capsugel)
• Chiesi Farmaceutici S.p.A
• Vectura Group Plc (Philip Morris International, Inc.)
• Elpen S.A.
• Healthcaps India Ltd.
• Qualicaps Co., LTD. (Roquette Freres SA)

North America Inhalation Capsules Market Report Segmentation

By Type

• Gelatin Capsules
• Hypromellose Capsules

By Application

• Asthma Treatment
• COPD Management
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Inhalation Capsules Market, by Type
1.4.2 North America Inhalation Capsules Market, by Application
1.4.3 North America Inhalation Capsules Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5. North America Inhalation Capsules Market by Type
5.1 North America Gelatin Capsules Market by Region
5.2 North America Hypromellose Capsules Market by Region

Chapter 6. North America Inhalation Capsules Market by Application
6.1 North America Asthma Treatment Market by Country
6.2 North America COPD Management Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Inhalation Capsules Market by Country
7.1 US Inhalation Capsules Market
7.1.1 US Inhalation Capsules Market by Type
7.1.2 US Inhalation Capsules Market by Application
7.2 Canada Inhalation Capsules Market
7.2.1 Canada Inhalation Capsules Market by Type
7.2.2 Canada Inhalation Capsules Market by Application
7.3 Mexico Inhalation Capsules Market
7.3.1 Mexico Inhalation Capsules Market by Type
7.3.2 Mexico Inhalation Capsules Market by Application
7.4 Rest of North America Inhalation Capsules Market
7.4.1 Rest of North America Inhalation Capsules Market by Type
7.4.2 Rest of North America Inhalation Capsules Market by Application

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Trials and Approvals:
8.2.6 SWOT Analysis
8.3 AstraZeneca PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 Boehringer Ingelheim International GmbH
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Lonza Group Ltd. (Capsugel)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Chiesi Farmaceutici S.p.A
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Vectura Group plc (Philip Morris International, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Geographical Expansions:
8.7.6 SWOT Analysis
8.8 Elpen S.A.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Healthcaps India Ltd.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Qualicaps Co., LTD. (Roquette Freres SA)
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 North America Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 2 North America Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 3 North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 4 North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 5 North America Gelatin Capsules Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Gelatin Capsules Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 10 North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 11 North America Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 13 North America COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 14 North America COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 19 US Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 20 US Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 21 US Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 22 US Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 23 US Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 24 US Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 25 Canada Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 26 Canada Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 27 Canada Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 28 Canada Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 29 Canada Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 30 Canada Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 31 Mexico Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 32 Mexico Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 33 Mexico Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 34 Mexico Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 35 Mexico Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 36 Mexico Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 37 Rest of North America Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 38 Rest of North America Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 39 Rest of North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 40 Rest of North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 41 Rest of North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 42 Rest of North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 43 Key Information – Cipla Limited
TABLE 44 Key Information – Novartis AG
TABLE 45 Key Information – AstraZeneca PLC
TABLE 46 Key Information – Boehringer Ingelheim International GmbH
TABLE 47 Key Information –Lonza Group Ltd.
TABLE 48 Key Information – Chiesi Farmaceutici S.p.A
TABLE 49 Key Information – Vectura Group plc
TABLE 50 Key Information – Elpen S.A.
TABLE 51 Key Information – Healthcaps India Ltd.
TABLE 52 Key Information – Qualicaps Co., LTD.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Inhalation Capsules Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Inhalation Capsules Market
FIG 4 Porter’s Five Forces Analysis – Inhalation capsules market
FIG 5 North America Inhalation Capsules Market share by Type, 2023
FIG 6 North America Inhalation Capsules Market share by Type, 2031
FIG 7 North America Inhalation Capsules Market by Type, 2020 - 2031, USD Million
FIG 8 North America Inhalation Capsules Market share by Application, 2023
FIG 9 North America Inhalation Capsules Market share by Application, 2031
FIG 10 North America Inhalation Capsules Market by Application, 2020 - 2031, USD Million
FIG 11 North America Inhalation Capsules Market share by Country, 2023
FIG 12 North America Inhalation Capsules Market share by Country, 2031
FIG 13 North America Inhalation Capsules Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Cipla Limited
FIG 15 SWOT Analysis: Novartis AG
FIG 16 Recent strategies and developments: AstraZeneca PLC
FIG 17 SWOT Analysis: AstraZeneca PLC
FIG 18 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 19 Swot Analysis: Lonza Group Ltd.
FIG 20 Recent strategies and developments: Chiesi Farmaceutici S.p.A.
FIG 21 SWOT Analysis: Chiesi Farmaceutici S.p.A
FIG 22 Recent strategies and developments: Vectura Group plc
FIG 23 Swot Analysis: Vectura Group plc
FIG 24 Swot Analysis: elpen s.a.
FIG 25 Swot Analysis: Healthcaps India Ltd.
FIG 26 Swot Analysis: Qualicaps Co., LTD.